Reyes Syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025


#8264

Transparency Market Research

$ 5795

Reye’s syndrome is a rare and critical condition which causes swelling of the brain and liver. The syndrome mainly affects young adults below the age of 20 and children who are recovering from chicken pox or any viral infection. The symptoms include continuous vomiting, lethargy, rapid breathing etc. The cause of the disease is unknown. It is believed that in Reye’s syndrome, mitochondria in the cell gets damaged, which are the powerhouse of the cells. Thus if the liver does not get energy supply, it fails, leading to accumulation of toxins, which can cause damage and swelling.

The global Reye’s syndrome market is expected to expand at a steady CAGR during the forecast period. Reye’s syndrome is a rare disease and occurs mainly in children with high fatality rate which is one of the important factors likely to drive Reye’s syndrome market during the forecast period. Usage of aspirin in the treatment of flu etc. in children is linked to Reye’s syndrome which is another factor, driving Reye’s syndrome market since aspirin is used very often. Factors such as increase in incidence of influenza and other viral infections are also expected to influence the growth of the global Reye’s syndrome market during the forecast period. Moreover, increase in R & D, surge in per capita expenditure, and government initiatives for children’s health are further driving the growth of the global Reye’s syndrome market. Lack of awareness of the condition in many developing countries, fewer treatment options etc are some of the factors restraining the growth of the global Reye’s syndrome market. 

The global Reye’s syndrome market can be segmented based on diagnosis, treatment, end users, and geographical regions. Based on diagnosis, Reye’s syndrome market can be classified into liver biopsies, imaging, blood tests and others. On the basis of treatment, Reye’s syndrome market can be divided into blood electrolytes and fluids, diuretics, ammonia detoxicants, anticonvulsants and others. Treatment for Reye’s syndrome includes minimizing the symptoms of the disease which is usually done in hospitals. Based on end users, the global Reye’s syndrome market can be classified into hospitals and clinics, diagnostic centers and others.

Geographically, the Reye’s syndrome market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate Reye’s syndrome market with the largest share. Increase in prevalence of viral diseases and usage of aspirin is leading to Reye’s syndrome which are some of the major factors driving the growth of Reye’s syndrome market in the region. Moreover, rise in awareness among people regarding diagnosis of the disease, high healthcare expenditure etc. are some of the factors attributed to the growth of the North America market. Europe is anticipated to hold second largest share of the global Reye’s syndrome market due to factors such as increase in healthcare investment, incidence of Reye’s syndrome in the region, entry of market players etc. The Asia Pacific Reye’s syndrome market is anticipated to register faster growth rate during the forecast period due to developing countries like India and China investing on healthcare expenditure, growing adolescent population, increasing number of biotechnology and pharmaceutical companies in the region etc. Furthermore, adoption of healthcare solutions for better standard of life, rising awareness about healthcare, increase in healthcare expenditure etc are some of the factors driving the growth of Reye’s syndrome market in the Asia Pacific region.

In order to obtain a significant position in the global Reye’s syndrome market, players are operating specific strategies such as robust R & D, collaboration, and acquisitions. Some of the key players operating in the global Reye’s syndrome market are Pfizer Inc., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Merck & Co., Inc. and others. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.